NCT07315932 Perception of Hormonal Replacement Therapy Among Patients Aged 11 to 17 Years
| NCT ID | NCT07315932 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Strasbourg, France |
| Condition | Female Hypogonadism |
| Study Type | OBSERVATIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-03-23 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 20 participants in total. It began in 2025-03-23 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To establish a current knowledge and perception of patients and their parents regarding HRT in order to assess the needs that can promote understanding and adherence to treatment by implementing therapeutic education workshops
Eligibility Criteria
Inclusion Criteria: * Female patients aged 11 to 18 years * Treated at the University Hospital of Strasbourg for central or peripheral hypogonadism with the initiation of hormone replacement therapy Exclusion Criteria: \- Inability to provide the subject with clear information (difficulties understanding the subject, language barrier, illiteracy, etc.)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07315932 clinical trial?
This trial is open to female participants only, aged 11 Years or older, up to 18 Years, studying Female Hypogonadism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07315932 currently recruiting?
Yes, NCT07315932 is actively recruiting participants. Contact the research team at mathilda.kretz@chru-strasbourg.fr for enrollment information.
Where is the NCT07315932 trial being conducted?
This trial is being conducted at Strasbourg, France.
Who is sponsoring the NCT07315932 clinical trial?
NCT07315932 is sponsored by University Hospital, Strasbourg, France. The trial plans to enroll 20 participants.